Connect Biopharma snags $115 million in Series C to develop arsenal of immune modulators
Zheng Wei and William Pan met in a molecular biology study group in college in Guangzhou, China.
In the following decades, the duo transformed from …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
